Vinati Organics Ltd
Vinati Organics Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
1 of 4 strong
The short version
FY26 growth was similar to FY25, around 5%. FY26 growth was modest at around 5% compared to FY25.
From Vinati Organics Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- FY26 growth was similar to FY25, around 5%.
- Targeting approximately 15% volume growth at the company level in FY27.
- Antioxidants segment delivered 15% revenue growth in FY26 and expected to maintain strong momentum in FY27.
- ATBS expected to see 15% volume growth year-on-year for the next 3 years.
- Butyl phenols expect moderate growth in FY27.
- IB and HP-MTBE expected to achieve double-digit growth in FY27.
- IBB volumes declined in FY26 due to raw material unavailability but production and sales are now back on track.
- Customized products showed strong 10% year-on-year growth, expected to continue.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Vinati Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY26 capex was approximately INR 270 crores, including investments in VOPL for capacity expansion, new product development, and operational scalability.
- FY27 capex is earmarked at around INR 200-250 crores focusing on capacity expansion, innovation, and operational efficiency.
- Major portion (~INR 200 crores) of FY27 capex will be through the main holding company Vinati Organics Limited; INR 40-50 crores through subsidiary VOPL.
- The ATBS capacity expansion completed, with further utilization expected from FY28 onwards.
- Process reengineering at VOPL expected to be completed by September 2026; revenue contribution from Q3 FY27.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Vinati Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- No explicit mention of a current or expected order book or pending orders was made in the transcript.
- For ATBS, capacity utilization is about 75-80%, indicating healthy demand, but no specific backlog figures were shared.
- Management indicated stable industry growth with expectations of approximately 15% volume growth in FY27.
- No direct references to order backlog numbers or pending orders were given during the Q&A.
- The company is focusing on organic expansion with planned capex of INR250-300 crores annually for product development and capacity enhancement.
2 more points management made on order book & pipeline
Vinati Organics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹611 Cr, net profit ₹138 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vinati Organics Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Chemfab Alka. (Q4 FY26)
Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key concall takeaways from Chemfab Alkalis Ltd's Q4 FY26 earnings call — and how it…
- Innovassynth Technologies (India) Ltd (Q4 FY26)
Order book improved by approximately INR 60 crore during the quarter, indicating strong customer demand and revenue visibility. Key concall takeaways from…
- Jubilant Agri & Consumer Products Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations: INR 4,852 MN, up 22% YoY from INR 3,983 MN in Q4 FY25 (Page 19) . Key concall takeaways from Jubilant Agri & Consumer Products…
- Bodal Chemicals Ltd (Q4 FY26)
5,906.0 mn, a 30.3% YoY growth from Rs. Key concall takeaways from Bodal Chemicals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were Vinati Organics Ltd Q4 FY26 results?
FY26 growth was similar to FY25, around 5%. FY26 growth was modest at around 5% compared to FY25.
What is Vinati Organics Ltd share price analysis?
Vinati Organics Ltd currently shows a below-average growth signal. The stock trades at a P/E of 27.6 with a market cap of ₹13,764 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vinati Organics Ltd planning capital expenditure?
FY26 capex was approximately INR 270 crores, including investments in VOPL for capacity expansion, new product development, and operational scalability.
Keep Vinati Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.